RTP gene editing startup Locus Biosciences lands $12.5M from 31 investors
The round, which kicked off on April 8, is capped at $15 million, with $2.5 million remaining to be sold. Funds raised will be used fo “payments of salary in the ordinary course of business,” the filing indicated.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed